Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

J&J's Care4Today brand joins Twitter

Firm's Janssen Healthcare Innovation unit also makes its debut on the social network

J&J Care4Today JHI Janssen TwitterJohnson & Johnson has expanded its use of Twitter, bringing its Care4Today brand and Janssen Healthcare Innovation unit to the social network.

Care4Today currently encompasses four areas - Mobile Health Manager, Mental Health Solutions, Heart Health Solutions and Orthopaedic Solutions - and forms part of transform J&J's plans to transform itself from a product-centric pharma business to a broader healthcare company.

The company, which came out top in our recent Digital Futures survey, has also brought its innovation unit to Twitter. Janssen Healthcare Innovation is set up as an entrepreneurial team within Janssen's R&D arm and behind a range of initiatives, including Care4Today.

Pharma and biotech companies on Twitter

25th February 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics